Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection July 27, 2023
Exploring bioinformatics approach for evaluating binding affinities of probable COVID-19 therapeutic decoys January 18, 2023
Happy New Year? Chinese supply chain face further delay and disruption – Digital Journal February 1, 2022
China, messages and online tributes: two years later there are those who do not forget Dr. Li Wenliang, Covid whistleblower December 31, 2021
Whistleblower sues to get NIH to release info on China request to scrub COVID info from database November 19, 2021
Whistleblower Sues NIH to Release Documents on China Removing COVID-19 Information from Database November 19, 2021
Covid-19 neither bioweapon nor genetically engineered, US intel says, but hints if China doesn’t cooperate it can reconsider October 30, 2021
With China's Travel Sector Possibly Depressed, What Will Qunar.com Do With Investment Money? April 16, 2013
Sinovac Biotech Ltd. Expects To Complete Human Influenza Vaccine Pre-Clinical Research By 200-End March 24, 2004
